View in EDS

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

Saved in:
Bibliographic Details
Title: PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.
Authors: Jensen, J. D.1,2, Knoop, A.1,2, Laenkholm, A. V.3, Grauslund, M.4, Jensen, M. B.5, Santoni-Rugiu, E.4, Andersson, M.6, Ewertz, M.1,2
Source: Annals of Oncology. Aug2012, Vol. 23 Issue 8, p2034-2042. 9p. 1 Diagram, 2 Charts, 2 Graphs.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 78117434
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Jensen%2C+J%2E+D%2E%22">Jensen, J. D.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Knoop%2C+A%2E%22">Knoop, A.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Laenkholm%2C+A%2E+V%2E%22">Laenkholm, A. V.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Grauslund%2C+M%2E%22">Grauslund, M.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Jensen%2C+M%2E+B%2E%22">Jensen, M. B.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Santoni-Rugiu%2C+E%2E%22">Santoni-Rugiu, E.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Andersson%2C+M%2E%22">Andersson, M.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Ewertz%2C+M%2E%22">Ewertz, M.</searchLink><relatesTo>1,2</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Aug2012, Vol. 23 Issue 8, p2034-2042. 9p. 1 Diagram, 2 Charts, 2 Graphs.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=78117434
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdr546
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 2034
    Titles:
      – TitleFull: PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jensen, J. D.
      – PersonEntity:
          Name:
            NameFull: Knoop, A.
      – PersonEntity:
          Name:
            NameFull: Laenkholm, A. V.
      – PersonEntity:
          Name:
            NameFull: Grauslund, M.
      – PersonEntity:
          Name:
            NameFull: Jensen, M. B.
      – PersonEntity:
          Name:
            NameFull: Santoni-Rugiu, E.
      – PersonEntity:
          Name:
            NameFull: Andersson, M.
      – PersonEntity:
          Name:
            NameFull: Ewertz, M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1